KALA BIO, Inc. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2ab0381b-6e9e-4086-a88b-630d31f81b3c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-043782 |
| FY 2024 | $0 | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-004081 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-004326 |
| FY 2022 | $3.9M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-002746 |
| FY 2021 | $11.2M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004624 |
| FY 2020 | $6.4M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001797 |
| FY 2019 | $6.1M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-000733 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-002697 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001558370-18-002697 |
| FY 2015 | $45.0k | 2015-01-01 – 2015-12-31 | evidence 0001558370-18-002697 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).